238
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer

, , , , , & show all
Pages 573-579 | Received 26 May 2013, Accepted 18 Jul 2013, Published online: 19 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xinlu Liu, Yejing Weng, Peng Liu, Zhigang Sui, Lei Zhou, Yinpeng Huang, Lihua Zhang, Yukui Zhang & Xiaodong Tan. (2018) Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics. OncoTargets and Therapy 11, pages 3345-3357.
Read now
Qidong Ye, Pan Fu, Jiaying Dou & Nina Wang. (2018) Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells. OncoTargets and Therapy 11, pages 2925-2935.
Read now
Zhaowei Yang, Juan Liu, Qinghong Shi, Yang Chao, Yanqing Di, Jing Sun, Jiebing Zhang, Lihong Huang, Honghua Guo & Chengyan He. (2018) Expression of protein disulfide isomerase A3 precursor in colorectal cancer. OncoTargets and Therapy 11, pages 4159-4166.
Read now
Wan Abd Ghani Wan Nor Hafiza & Saiful Yazan Latifah. (2014) Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy. OncoTargets and Therapy 7, pages 1375-1387.
Read now

Articles from other publishers (16)

Fanrong Yu, Xin Liu, Min Li, Xiufen Liu, Xintai Wang & Meixiang Guo. (2023) Protein disulfide isomerase A3 as novel biomarker for endometrial cancer. Frontiers in Oncology 13.
Crossref
Jing Zhang, Hui Li, Huling Li, Dandan Lin, Xiaoyan Wang & Kai Wang. (2022) Expression and Prognostic Significance of PDIA3 in Cervical Cancer. International Journal of Genomics 2022, pages 1-25.
Crossref
Ming Sun, Shanshan Qi, Min Wu, Wei Xia & Hao Xiong. (2022) Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Frontiers in Genetics 13.
Crossref
Jing Zhang, Kai Wang, Tuersun Hainisayimu & Hui Li. (2022) Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy. Oxidative Medicine and Cellular Longevity 2022, pages 1-42.
Crossref
Shoko Kure, Tomohiro Chiba, Aya Ebina, Kazuhisa Toda, Tomoo Jikuzono, Norio Motoda, Hiroki Mitani, Iwao Sugitani, Kengo Takeuchi & Ryuji Ohashi. (2022) Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up. Endocrine Journal 69:3, pages 273-281.
Crossref
Robert J. Walsh & David S. P. Tan. (2021) The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives. Journal of Clinical Medicine 10:19, pages 4523.
Crossref
Anastasia Mpakali & Efstratios Stratikos. (2021) The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy. Cancers 13:1, pages 134.
Crossref
Fatemeh Rahbar, Avid Farhang Fagheh, Ayda Khosravi, Siavash Shariatzadeh & Reza Akhavan-Sigari. (2021) A Review of the Role of ERp57 in Cancerous and Non-Cancerous Cell Physiology and its Potential as a Therapeutic Target. Molecular & Cellular Biomechanics 18:4, pages 187-199.
Crossref
Henry S. YoungLucy M. McGowanKaty A. JepsonJosephine C. Adams. (2020) Impairment of cell adhesion and migration by inhibition of protein disulphide isomerases in three breast cancer cell lines. Bioscience Reports 40:10.
Crossref
Barbara Seliger & Soldano Ferrone. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer 325 350 .
Aubryanna Hettinghouse, Ronghan Liu & Chuan-ju Liu. (2018) Multifunctional molecule ERp57: From cancer to neurodegenerative diseases. Pharmacology & Therapeutics 181, pages 34-48.
Crossref
Jian-Zhong He, Zhi-Yong Wu, Shao-Hong Wang, Xia Ji, Cui-Xia Yang, Xiu-E Xu, Lian-Di Liao, Jian-Yi Wu, En-Min Li, Kai Zhang & Li-Yan Xu. (2017) A decision tree–based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma. Human Pathology 66, pages 115-125.
Crossref
Emma Reeves & Edward James. (2017) Antigen processing and immune regulation in the response to tumours. Immunology 150:1, pages 16-24.
Crossref
Hideyuki Takata, Mitsuhiro Kudo, Tetsushi Yamamoto, Junji Ueda, Kousuke Ishino, Wei-Xia Peng, Ryuichi Wada, Nobuhiko Taniai, Hiroshi Yoshida, Eiji Uchida & Zenya Naito. (2016) Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma. Oncology Letters 12:6, pages 4896-4904.
Crossref
SHUZHEN ZHAO, ZHENGFANG WEN, SHANSHAN LIU, YING LIU, XIAORUI LI, YANNA GE & SHAORU LI. (2015) MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3. Molecular Medicine Reports 12:3, pages 3923-3929.
Crossref
Wilhelmina C. M. Duivenvoorden, Athanasios Paschos, Sarah N. Hopmans, Richard C. Austin & Jehonathan H. Pinthus. (2014) Endoplasmic Reticulum Protein ERp46 in Renal Cell Carcinoma. PLoS ONE 9:3, pages e90389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.